90 related articles for article (PubMed ID: 17201162)
1. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
[TBL] [Abstract][Full Text] [Related]
2. Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP; Pries R; Frenzel H; Ernst M; Schlenke P; Wollenberg B
Anticancer Res; 2007; 27(2):817-24. PubMed ID: 17465207
[TBL] [Abstract][Full Text] [Related]
3. Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood.
Brocks C; Graefe H; Frenzel H; Pries R; Wollenberg B
In Vivo; 2006; 20(2):239-42. PubMed ID: 16634524
[TBL] [Abstract][Full Text] [Related]
4. Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein.
Frenzel H; Pries R; Brocks CP; Jabs WJ; Wittkopf N; Wollenberg B
Anticancer Res; 2007; 27(6B):4111-5. PubMed ID: 18225580
[TBL] [Abstract][Full Text] [Related]
5. Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A; Pries R; Jeske S; Trenkle T; Wollenberg B
Anticancer Res; 2009 Aug; 29(8):3019-25. PubMed ID: 19661310
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7.
Pries R; Wulff S; Kesselring R; Börngen K; Xie L; Wollenberg B
Int J Oncol; 2008 Nov; 33(5):993-1000. PubMed ID: 18949362
[TBL] [Abstract][Full Text] [Related]
9. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
Pries R; Thiel A; Brocks C; Wollenberg B
In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
[TBL] [Abstract][Full Text] [Related]
10. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
11. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
Pries R; Hogrefe L; Xie L; Frenzel H; Brocks C; Ditz C; Wollenberg B
Int J Mol Med; 2008 Feb; 21(2):209-15. PubMed ID: 18204787
[TBL] [Abstract][Full Text] [Related]
12. Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation.
Riebe C; Pries R; Kemkers A; Wollenberg B
Int J Mol Med; 2007 Dec; 20(6):883-7. PubMed ID: 17982698
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma.
Thiel A; Kesselring R; Pries R; Wittkopf N; Puzik A; Wollenberg B
Oncol Rep; 2011 Sep; 26(3):615-20. PubMed ID: 21687955
[TBL] [Abstract][Full Text] [Related]
14. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
15. Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands.
Terhorst D; Kalali BN; Weidinger S; Illig T; Novak N; Ring J; Ollert M; Mempel M
Clin Exp Allergy; 2007 Mar; 37(3):381-90. PubMed ID: 17359388
[TBL] [Abstract][Full Text] [Related]
16. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
17. Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer.
Wild CA; Brandau S; Lindemann M; Lotfi R; Hoffmann TK; Lang S; Bergmann C
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1253-9. PubMed ID: 21173376
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer triggers the internalization of TLR3 in natural killer cells.
Xie L; Pries R; Kesselring R; Wulff S; Wollenberg B
Int J Mol Med; 2007 Oct; 20(4):493-9. PubMed ID: 17786279
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.
Broering R; Wu J; Meng Z; Hilgard P; Lu M; Trippler M; Szczeponek A; Gerken G; Schlaak JF
J Hepatol; 2008 Jun; 48(6):914-22. PubMed ID: 18362039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
